Depression and Anxiety
- Discuss the major risk factors for both depression and anxiety
- Cite barriers to diagnosing depression and anxiety in a primary care setting
- Screen patients at risk, with an emphasis on age related assessment considerations
- Identify tools to conduct a thorough, individualized depression assessment and an effective interview
- Differential diagnosis and treatment intervention options for comorbid depression and anxiety
| Essentials in Women’s Health for Primary Care Fibromyalgia: An Interactive Workshop Pain and Depression Depression and Anxiety Saturday, 10 April 7:00 AM - 12:15 PM Westin City Center, 650 North Pearl Street Dallas, TX 75201 Tel 214.979.9000 | Fax 214.953.1931 |
Fibromyalgia:
- Identify symptoms commonly associated with FMS beyond chronic widespread pain and tenderness.
- Actively develop differential diagnoses for patients presenting with chronic fatigue, disturbed sleep,
and neuropsychiatric disturbances, including anxiety/mood disturbances and cognitive dysfunction. - Order and utilize laboratory and imaging studies that may be helpful in the development of differential
diagnoses. - Create a treatment plan through integrative approach to symptom management of non-pharmacologic
and pharmacologic treatment. - Recognize the three main therapeutic areas that need to be considered (pain, sleep, mood disorders).
- Review and identify components of effective physician-patient communication practices that hinder or
promote positive response and patient satisfaction. - Integrate and apply motivational interviewing and patient-centered approaches for change or treatment
compliance and determine appropriate response to promote positive clinical experiences.
Accreditation Statement:
The American Academy of Physician Education is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to
provide continuing medical education for physicians. The American Academy of Physician Education takes responsibility for the content, quality
and scientific integrity of this CME activity.
Credit Designation Statement:
The American Academy of Physician Education designates this educational activity for a maximum of 4.0 hours AMA PRA Category 1 Credit(s)™.
Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA
Certification in Continuing Medical Education.
The American Academy of Physician Education is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to
provide continuing medical education for physicians. The American Academy of Physician Education takes responsibility for the content, quality
and scientific integrity of this CME activity.
Credit Designation Statement:
The American Academy of Physician Education designates this educational activity for a maximum of 4.0 hours AMA PRA Category 1 Credit(s)™.
Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA
Certification in Continuing Medical Education.
Target Audience:
Family practitioners, general practitioners and internists who treat women
Family practitioners, general practitioners and internists who treat women
Learning Objectives:
| Key Speakers: Rakesh Jain, MD, MPH Jon Draud, MS, MD (view bios) |
Agenda:
7:00AM – 7:45AM Registration and Breakfast
7:45AM – 8:00AM Welcome and Introduction
8:00AM – 10:00AM Fibromyalgia: An interactive workshop – Rakesh Jain, MD, MPH
10:00AM – 10:15AM Break
10:15AM – 11:15AM Depression and Pain – Jon Draud, MS, MD
11:15AM – 12:15AM Depression and Anxiety – Jon Draud, MS, MD
7:00AM – 7:45AM Registration and Breakfast
7:45AM – 8:00AM Welcome and Introduction
8:00AM – 10:00AM Fibromyalgia: An interactive workshop – Rakesh Jain, MD, MPH
10:00AM – 10:15AM Break
10:15AM – 11:15AM Depression and Pain – Jon Draud, MS, MD
11:15AM – 12:15AM Depression and Anxiety – Jon Draud, MS, MD
Commercial Support: This activity is supported by educational grants from Eli Lilly and Company, Forest Laboratories, Inc. and Pfizer.
Pain and Depression:
- Diagnose depression in patients presenting with somatic complaints
- Prescribe effective treatments for the painful physical conditions associated with depression
- Prescribe effective treatments for neuropathic pain and fibromyalgia